Abstract
Introduction: Meperidine is a synthetic opioid analog that is frequently prescribed for acute pain management. Normeperidine, the only active metabolite of meperidine, is neurotoxic and can cause significant central nervous system adverse events.
Case summary: A 29-year-old woman (height, 170 cm; weight, 85 kg) presented to Marmara University Hospital Emergency Department, Istanbul, Turkey, complaining of low back pain she described as “stabbing.” Physical examination revealed impaired lower-extremity mobility and normal vital-sign findings. There was no evidence of foot drop, head or other trauma, and systemic physical examination was unremarkable. Other common causes (eg, pyelonephritis, nephrolithiasis, pancreatitis, trauma) of lower back pain were excluded. To achieve analgesia, meperidine 80 mg was administered intravenously in 100 mL of isotonic saline solution for 20 minutes. Within 20 minutes,analgesia was achieved,but the patient developed retrograde amnesia, becoming disoriented to time, location, and persons. Her speech slowed and perceptional changes developed. After the onset of amnesia, a complete physical examination was conducted.It failed to reveal focal neurologic deficit,and laboratory (sodium, potassium, magnesium, phosphorus, serum creatinine, blood urea nitrogen, albumin, bilirubin, hemoglobin,and platelet count) and subsequent vital-sign findings (blood pressure, 150/100 mm Hg; heart rate, 100 beats per minute; respiratory rate, 18 breaths per minute; body temperature, 37 ଌ and pulse oximetry,99%) were within the normal range. Noncontrast computed tomography did not reveal any abnormality. Initially, the patient's condition was attributed to medication error due to incorrect dosage or infusion rate. Despite a review of medication logs, equipment, and the vital-sign record, the etiology for the phenomenon could not be identified. Meperidine was discontinued and oxygen and intravenous isotonic saline solution were initiated as supportive treatment. Three hours after meperidine administration was discontinued, the amnesia and disorientation spontaneously resolved.
Conclusion: Meperidine was probably associated with reversible amnesia in this healthy patient after a single therapeutic dose.
Key words: meperidine, amnesia, opioid analgesic, central nervous system toxicity
Full Text
The Full Text of this article is available as a PDF (457.3 KB).
References
- 1.Demerol Prescribing Information [FDA Web site].; June 27, 2007. http://www.fda.gov/medwatch/SAFETY/2003/3Feb_PI/Demerol_PI.pdf Accessed.
- 2.Chalverus CA. Clinically important meperidine toxicities. J Pharm Care Pain Symptom Control. 2001;9:37–55. [Google Scholar]
- 3.Latta KS, Ginsberg B, Barkin RL. Meperidine: A critical review. Am J Ther. 2002;9:53–68. doi: 10.1097/00045391-200201000-00010. [DOI] [PubMed] [Google Scholar]
- 4.Morrison RS, Magaziner J, Gilbert M. Relationship between pain and pioid analgesics on the development of delirium following hip fracture. J Gerontol A Biol Sci Med Sci. 2003;58:76–81. doi: 10.1093/gerona/58.1.m76. [DOI] [PubMed] [Google Scholar]
- 5.American Pain Society . Principles of Analgesic Use in the Treatment of Acute Pain and Cancer Pain. 5th ed. American Pain Society; Glenview, III: 2003. [Google Scholar]
- 6.Kaye KI, Welch SA, Graudins LV. Pethidine in emergency departments: Promoting evidence-based prescribing. Med J Aust. 2005;183:129–133. [PubMed] [Google Scholar]
- 7.Simopoulos TT, Smith HS, Peeters-Asdourian C. Stevens S. Use of meperidine in patient-controlled analgesia and the development of a normeperidine toxic reaction. Arch Surg. 2002;137:84–88. doi: 10.1001/archsurg.137.1.84. [DOI] [PubMed] [Google Scholar]
- 8.Quraishi SA, Girdharry TD, Xu SG. Orkin FK. Prolonged retrograde amnesia following sedation with propofol in a 12-year-old boy. Pediatr Anesth. 2007;17:375–379. doi: 10.1111/j.1460-9592.2006.02123.x. [DOI] [PubMed] [Google Scholar]
- 9.World Health Organization. The safety of medicines. Fact Sheet 293. [WHO Web site]; March 4, 2008. http://www.who.int/mediacentre/factsheets/fs293/en Accessed.
- 10.Leikin JB, Paloucek FP. Poisoning & Toxicology Compendium: With Symptoms Index. Lexi-Comp, Inc; Hudson, Ohio: 1998. pp. 371–372. [Google Scholar]
- 11.McCaffery M, Pasero C. Pain: Clinical Manual. 2nd ed. St. Louis, Mo; Mosby: 1999. Opioid analgesics; pp. 161–199. [Google Scholar]
- 12.Taylor SE, Braitberg G, Lugt J. Multifaceted education initiative minimizes pethidine prescribing in the emergency department. Emerg Med Australas. 2007;19:25–30. doi: 10.1111/j.1742-6723.2006.00911.x. [DOI] [PubMed] [Google Scholar]
- 13.Turkish Ministry of Health, Ankara,Turkey.; March 4, 2008. http://www.http://www.saglik.gov.tr Accessed.
- 14.Naranjo CA, Busto U, Sellers EM. et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239–245. doi: 10.1038/clpt.1981.154. [DOI] [PubMed] [Google Scholar]